CIGNA Corporation (NYSE:CI) – market cap as of 09/03/2018: $42.7bn Express Scripts Holding Co (NASDAQ:ESRX) – market cap as of 09/03/2018: $45.7bn Introduction On March 8, 2018, Cigna Corporation announced the acquisition of Express Scripts Holding for a cash and stock consideration of $67bn. The combination of Cigna – a Read more…
Rite Aid (NYSE:RAD) – market cap as of 23/02/2018: $2.22bn Introduction On the 20th February, Rite Aid Corporation, one of the leading US drugstore chains, entered into a definitive merger agreement with Albertsons Companies, one of the largest American private equity-backed grocery retailers. The deal will result in the creation of a Read more…
Stada Arzneimittel AG (FWB: SAZ) – market cap as of 21/04/2017: €4.02bn Intel Cinven Partners LLP – private company – AUM as of FY 2015: €10.60bn Bain Capital Private Equity, LP – private company – AUM as of 04/04/2017: $32.40bn Introduction On April 10, 2017, Bain Capital Private Equity, LP Read more…
Johnson & Johnson (NYSE: JNJ) — market cap as of 10/02/2017: $310.36bn Actelion (VTX: ATLN) – market cap as of 10/02/2017: CHF 28.13bn Introduction On the January 26, 2017, the US healthcare behemoth Johnson & Johnson announced the acquisition of the Swiss biotech company Actelion for $30bn in cash. Read more…
Pfizer Inc.; market cap (as of 20/02/2015): US$217.75bn Hospira Inc.; market cap (as of 20/02/2015): US$14.97bn Introduction On February 5th, 2014, pharmaceutical behemoth Pfizer signed with Hospira, the world’s leading provider of injectable drugs and biosimilars, a definitive merger agreement which consists of the fully acquisition of Hospira for US$90 Read more…